scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/J.PLEFA.2008.09.003 |
P698 | PubMed publication ID | 18938067 |
P2093 | author name string | Richard P Bazinet | |
Sarah K Orr | |||
Chuck T Chen | |||
Joshua T Green | |||
P2860 | cites work | Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex | Q28577710 |
Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex | Q28577930 | ||
Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks | Q28578836 | ||
Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. | Q48146045 | ||
Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. | Q48375218 | ||
n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism | Q48418353 | ||
P433 | issue | 3-5 | |
P921 | main subject | fatty acid | Q61476 |
P304 | page(s) | 85-91 | |
P577 | publication date | 2008-09-01 | |
P1433 | published in | Prostaglandins, Leukotrienes and Essential Fatty Acids | Q15753414 |
P1476 | title | Regulation of brain polyunsaturated fatty acid uptake and turnover | |
P478 | volume | 79 |
Q48179515 | A minimum of 3 months of dietary fish oil supplementation is required to raise amygdaloid afterdischarge seizure thresholds in rats--implications for treating complex partial seizures |
Q43162767 | Acute administration of docosahexaenoic acid increases resistance to pentylenetetrazol-induced seizures in rats |
Q38150523 | Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline |
Q41626312 | Akt3 is a privileged first responder in isozyme-specific electrophile response. |
Q34387949 | Associations of fatty acids in cerebrospinal fluid with peripheral glucose concentrations and energy metabolism |
Q48161221 | Attenuation of lead neurotoxicity by supplementation of polyunsaturated fatty acid in Wistar rats |
Q29248873 | Biological relevance of fatty acyl heterogeneity to the neural membrane dynamics of Rhesus macaques during normative aging |
Q42921801 | Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet |
Q91942413 | Cerebrospinal fluid lipidomics: effects of an intravenous triglyceride infusion and apoE status |
Q28484558 | Characterizing the network of drugs and their affected metabolic subpathways |
Q47669070 | Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats |
Q100332922 | Crosstalk Between Autophagy and Ferroptosis and Its Putative Role in Ischemic Stroke |
Q34559890 | Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma |
Q37939806 | Dietary lipids and their oxidized products in Alzheimer's disease. |
Q48370044 | Differential fatty acid analysis of cerebrospinal fluid in infants and young children with suspected meningitis. |
Q26768442 | Docosahexaenoic Acid and Cognition throughout the Lifespan |
Q45963329 | Docosahexaenoic acid (DHA) prevents corticosterone-induced changes in astrocyte morphology and function. |
Q22251219 | Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? |
Q64054875 | Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease |
Q45944961 | Effect of the non-steroidal anti-inflammatory drugs on the acyl-CoA synthetase activity toward medium-chain, long-chain and polyunsaturated fatty acids in mitochondria of mouse liver and brain. |
Q89964003 | Electrophile Signaling and Emerging Immuno- and Neuro-modulatory Electrophilic Pharmaceuticals |
Q38715276 | Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases |
Q64092813 | Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors |
Q47945490 | Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. |
Q39273375 | Fatty acid transporting proteins: Roles in brain development, aging, and stroke |
Q33552039 | Fluorescent n-3 and n-6 very long chain polyunsaturated fatty acids: three-photon imaging in living cells expressing liver fatty acid-binding protein |
Q52360936 | Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders. |
Q38159739 | Fortification of foods with omega-3 polyunsaturated fatty acids |
Q91868662 | Impact of diet-derived signaling molecules on human cognition: exploring the food-brain axis |
Q38131891 | Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma |
Q33849059 | Linoleic acid participates in the response to ischemic brain injury through oxidized metabolites that regulate neurotransmission |
Q92465194 | Linoleic acid-good or bad for the brain? |
Q39140990 | Lipid peroxidation in cell death |
Q64074236 | Lipids at the Crossroad of α-Synuclein Function and Dysfunction: Biological and Pathological Implications |
Q52641136 | Mancozeb exposure results in manganese accumulation and Nrf2-related antioxidant responses in the brain of common carp Cyprinus carpio. |
Q37603251 | Novel approach in LC-MS/MS using MRM to generate a full profile of acyl-CoAs: discovery of acyl-dephospho-CoAs |
Q47145569 | Novel strategies of Raman imaging for brain tumor research |
Q93078497 | Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials |
Q37244564 | Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial. |
Q34553032 | Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy |
Q38046539 | Overlapped metabolic and therapeutic links between Alzheimer and diabetes. |
Q89017853 | Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity |
Q38074802 | Oxidative damage to macromolecules in human Parkinson disease and the rotenone model |
Q35117457 | Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease |
Q34630947 | Phospholipase A2 - nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairment |
Q47847350 | Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence |
Q82524087 | Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study |
Q47439026 | Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets |
Q36921968 | Relationship between central and peripheral fatty acids in humans |
Q36832988 | Retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with obesity |
Q45771266 | Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats. |
Q37253465 | Sexually dimorphic brain fatty acid composition in low and high fat diet-fed mice |
Q36209750 | The Effects of Long-Term Saturated Fat Enriched Diets on the Brain Lipidome. |
Q47909646 | The effect of fish oil supplementation on brain DHA and EPA content and fatty acid profile in mice. |
Q43153227 | The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. |
Q42541702 | The low levels of eicosapentaenoic acid in rat brain phospholipids are maintained via multiple redundant mechanisms. |
Q37846445 | The neurobiology of lipid metabolism in autism spectrum disorders |
Q26829767 | The role of lipid peroxidation in neurological disorders |
Q37937303 | The use of omega-3 fatty acids in mental illness |
Q53347902 | Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study. |
Q64866429 | α-Synuclein and Polyunsaturated Fatty Acids: Molecular Basis of the Interaction and Implication in Neurodegeneration |
Search more.